Nicholas M Donin
Overview
Explore the profile of Nicholas M Donin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
1925
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ells Z, Ludwig V, Weiner A, Kimura K, Farolfi A, Chamie K, et al.
Methods
. 2025 Feb;
236:10-16.
PMID: 39988309
Introduction: Surgeons commonly use cross sectional images to plan and prepare for surgical procedures. However, cognitively translating 2D images to surgical settings can be difficult and lead to sub-optimal resections....
2.
Kianian R, Belarmino A, Finkelshtein I, Mills J, Eleswarapu S, Donin N
Transl Androl Urol
. 2023 Nov;
12(10):1561-1567.
PMID: 37969777
Background: Sperm banking refers to the collection and storage of sperm cells for future use. Despite the recommendations of major medical societies, sperm banking is not discussed sufficiently with patients...
3.
Kianian R, Eleswarapu S, Donin N
Urol Case Rep
. 2023 Mar;
47:102354.
PMID: 36866337
Hyperandrogenism secondary to testicular cancer typically arises in patients in whom Leydig cell hyperplasia or neoplasia can be identified. Additionally, benign and malignant adrenocortical tumors can also present with signs...
4.
Patel P, Osadchiy V, Quirk M, Dunn M, Donin N
Cardiovasc Intervent Radiol
. 2022 Mar;
45(7):1027-1029.
PMID: 35296932
No abstract available.
5.
Muraki P, Donin N
Urol Case Rep
. 2021 Sep;
39:101822.
PMID: 34485088
Ureteritis cystica is a rare condition of the upper urinary tract characterized by the presence of numerous small cystic lesions. Associated urinary tract malignancy is exceedingly rare, and ureteritis cystica...
6.
Huang W, Donin N, Levey A, Campbell S
J Urol
. 2019 May;
203(3):475-485.
PMID: 31063051
Purpose: We sought to provide a contemporary understanding of chronic kidney disease and its relevance to kidney cancer surgery. Another purpose was to resolve points of discrepancy regarding the survival...
7.
Donin N, Kwan L, Lenis A, Drakaki A, Chamie K
Cancer Causes Control
. 2019 Mar;
30(5):465-475.
PMID: 30900065
Purpose: Lung cancer is common and lethal, and can occur in survivors of previous cancers. We sought to describe the incidence and mortality attributable to second primary lung cancers (SPLC)...
8.
Lenis A, Asanad K, Blaibel M, Donin N, Chamie K
BMC Urol
. 2018 Oct;
18(1):93.
PMID: 30355350
Background: Intravesical Mitomycin-C (MMC) following transurethral resection of bladder tumor (TURBT), while efficacious, is associated with side effects and poor utilization. Continuous saline bladder irrigation (CSBI) has been examined as...
9.
Rude T, Donin N, Cohn M, Meeks W, Gulig S, Patel S, et al.
Urology
. 2018 Jun;
119:79-84.
PMID: 29885778
Objective: To define the rates of common hospital acquired conditions (HACs) in patients undergoing major urologic surgery over a period of time encompassing the implementation of the Hospital Acquired Condition...
10.
Lenis A, Asanad K, Blaibel M, Donin N, Chamie K
Urol Pract
. 2018 Mar;
5(2):132-138.
PMID: 29577063
Introduction: Intravesical bacillus Calmette-Guérin (BCG) therapy is the gold standard adjuvant treatment for patients with high-grade non-muscle-invasive bladder cancer (NMIBC). Despite the association between metabolic syndrome (MetS) and bladder cancer,...